BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 1224435)

  • 61. Age-related probability of development of hereditary medullary thyroid carcinoma.
    Gagel RF; Jackson CE; Block MA; Feldman ZT; Reichlin S; Hamilton BP; Tashjian AH
    J Pediatr; 1982 Dec; 101(6):941-6. PubMed ID: 7143171
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Familial medullary carcinoma of the thyroid.
    Block MA; Horn RC; Miller JM; Barrett JL; Brush BE
    Ann Surg; 1967 Sep; 166(3):403-12. PubMed ID: 6039599
    [No Abstract]   [Full Text] [Related]  

  • 63. [Familial surveys in screening for thyroid cancers with amyloid stroma. Report of a personal survey carried out on 80 members of the same family].
    Allannic H; Lorcy Y; Cornec A; Le Marec B; Calmettes C
    Ann Endocrinol (Paris); 1980; 41(1):31-41. PubMed ID: 7396392
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Familial medullary thyroid carcinoma and pheochromocytoma: epidemiologic investigations.
    Li FP; Melvin KE; Tashjian AH; Levine PH; Fraumeni JF
    J Natl Cancer Inst; 1974 Jan; 52(1):285-7. PubMed ID: 4359415
    [No Abstract]   [Full Text] [Related]  

  • 65. Whisky: a new provacative test for calcitonin secretion.
    Dymling JF; Ljungberg O; Hillyard CJ; Greenberg PB; Evans IM; MacIntyre I
    Acta Endocrinol (Copenh); 1976 Jul; 82(3):500-9. PubMed ID: 947123
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Management of familial medullary thyroid carcinoma and phaeochromocytoma.
    Beaugie JM; Belchetz PE; Brown CL; Frankel RJ; Lloyd MH
    Proc R Soc Med; 1975 Mar; 68(3):179. PubMed ID: 1166060
    [No Abstract]   [Full Text] [Related]  

  • 67. Medullary thyroid carcinoma and phaeochromocytoma: a familial chromaffinomatosis.
    Ljungberg O; Cederquist E; von Studnitz W
    Br Med J; 1967 Feb; 1(5535):279-81. PubMed ID: 6017480
    [No Abstract]   [Full Text] [Related]  

  • 68. On the occurrence of monoamines and related substances in familial medullary thyroid carcinoma with phaeochromocytoma.
    Falck B; Ljungberg O; Rosengren E
    Acta Pathol Microbiol Scand; 1968; 74(1):1-10. PubMed ID: 5700277
    [No Abstract]   [Full Text] [Related]  

  • 69. Familial amyloid-producing medullary thyroid carcinoma and pheochromocytoma. A distinct genetic entity.
    Schimke RN; Hartmann WH
    Ann Intern Med; 1965 Dec; 63(6):1027-39. PubMed ID: 5844561
    [No Abstract]   [Full Text] [Related]  

  • 70. Pheochromocytoma in father and son: report of the eighth known affected kindred.
    GREENBERG RE; GARDNER LI
    J Clin Endocrinol Metab; 1959 Mar; 19(3):351-62. PubMed ID: 13631052
    [No Abstract]   [Full Text] [Related]  

  • 71. Non-invasive prenatal diagnosis of multiple endocrine neoplasia type 2A using COLD-PCR combined with HRM genotyping analysis from maternal serum.
    Macher HC; Martinez-Broca MA; Rubio-Calvo A; Leon-Garcia C; Conde-Sanchez M; Costa A; Navarro E; Guerrero JM
    PLoS One; 2012; 7(12):e51024. PubMed ID: 23236420
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Management of medullary thyroid carcinoma and MEN2 syndromes in childhood.
    Waguespack SG; Rich TA; Perrier ND; Jimenez C; Cote GJ
    Nat Rev Endocrinol; 2011 Aug; 7(10):596-607. PubMed ID: 21862994
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Multiple endocrine neoplasia type 2.
    Marini F; Falchetti A; Del Monte F; Carbonell Sala S; Tognarini I; Luzi E; Brandi ML
    Orphanet J Rare Dis; 2006 Nov; 1():45. PubMed ID: 17105651
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Somatic VHL gene alterations in MEN2-associated medullary thyroid carcinoma.
    Koch CA; Brouwers FM; Vortmeyer AO; Tannapfel A; Libutti SK; Zhuang Z; Pacak K; Neumann HP; Paschke R
    BMC Cancer; 2006 May; 6():131. PubMed ID: 16707008
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Importance of early diagnosis and follow-up in multiple endocrine neoplasia (MEN II B).
    Frank K; Raue F; Gottswinter J; Heinrich U; Meybier H; Ziegler R
    Eur J Pediatr; 1984 Dec; 143(2):112-6. PubMed ID: 6394335
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Surgical management of the adrenal glands in the multiple endocrine neoplasia type II syndrome.
    van Heerden JA; Sizemore GW; Carney JA; Grant CS; ReMine WH; Sheps SG
    World J Surg; 1984 Aug; 8(4):612-21. PubMed ID: 6148811
    [No Abstract]   [Full Text] [Related]  

  • 77. Clonidine-induced suppression of plasma catecholamines in states of adrenal medulla hyperfunction.
    Gross MD; Shapiro B; Sisson JC; Zweifler A
    J Endocrinol Invest; 1987 Aug; 10(4):359-64. PubMed ID: 2890683
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Multiple endocrine neoplasia.
    Decker RA; Wells SA
    Jpn J Surg; 1989 Nov; 19(6):645-57. PubMed ID: 2575183
    [TBL] [Abstract][Full Text] [Related]  

  • 79. The two-mutational-event theory in medullary thyroid cancer.
    Jackson CE; Block MA; Greenawald KA; Tashjian AH
    Am J Hum Genet; 1979 Nov; 31(6):704-10. PubMed ID: 517520
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Natural history of the familial medullary thyroid carcinoma-pheochromocytoma syndrome and the identification of preneoplastic stages by screening studies: a five-year report.
    Gagel RF; Melvin KE; Tashjian AH; Miller HH; Feldman ZT; Wolfe HJ; DeLellis RA; Cerviskinner S; Reichlin S
    Trans Assoc Am Physicians; 1975; 88():177-91. PubMed ID: 1224435
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.